Advertisement
open access
Medical Conferences
Conference Reports
2024 Medicom Conference Planning
Conference Proceedings
Disease Areas
Medical News
Multimedia
Podcast Channel
Videos
Webinar
About
Conference Proceedings
Home
>
Cardiology
>
ISTH 2020
ISTH 2020
International Society on Thrombosis and Haemostasis
12-14 July 2020
Read the full Report (e-book)
Table of Contents
Colophon
Table of Contents
Featured articles
Letter from the Editor
Editor
Prof. Marc P. Bonaca, University of Colorado, USA
ISTH 2020 Highlights Podcast
Presented By
Dr Rachel Giles, Medicom
Haemophilia and Rare Bleeding Disorders
Sponsored content – staggering results from Trial 21487PH
Presented By
Prof.J.P.Haas
Novel gene therapy leads to normal FIX activity levels in severe haemophilia B
Presented By
Dr Pratima Chowdary, Royal Free London NHS Foundation Trust, United Kingdom
Haemophilia gene therapy: progress and obstacles
Presented By
Prof. Amit Nathwani, University College London, United Kingdom
Recombinant factor VIII safe and effective in PUPs A-LONG study
Presented By
Dr Christoph Königs, University Hospital Frankfurt, Germany
What’s New in Anticoagulation
Finding the sweet spot of anticoagulation in AF patients with ACS
Presented By
Prof. Renato D. Lopes, Duke University School of Medicine, USA
Lower embryopathy risk with DOAC versus VKA during pregnancy
Presented By
Dr Jan Beyer-Westendorf, UNI-Klinikum Carl Gustav Carus Medizinische Klinik I, Germany
Higher thrombotic risk in NSCLC patient with ALK rearrangement
Presented By
Dr Hanny Al-Samkari, Massachusetts General Hospital, USA
COVID-19 and Thrombosis
Crosstalk between inflammation and coagulation in severe COVID-19 infections
Presented By
Prof. Roberta Gualtierotti, University of Milan, Italy
COVID-19 associated with higher VTE rates relative to influenza
Presented By
Dr Milou Stals, Leiden University Medical Centre, the Netherlands
Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients
Presented By
Dr Hanny Al-Samkari, Massachusetts General Hospital, USA
COVID-19 not associated with heightened VTE risk after discharge
Presented By
Dr Matthias Engelen, University Hospital Leuven, Belgium
What’s New in Venous Thromboembolism
Residual pulmonary obstruction may predict risk of VTE recurrence
Presented By
Dr Robin Chaux, University Hospital St. Etienne, France
Less diagnostic delay in CTEPH diagnosis with novel algorithm
Presented By
Dr Gudula Boon, Leiden University Medical Center, the Netherlands
Risk of checkpoint inhibitor-associated thromboembolic events important for cancer prognosis
Presented By
Dr Florian Moik, Medical university of Vienna, Austria
Pearls of the Posters
Surgical bleeding risk most important determinant of bleeding outcomes
Presented By
Dr Kira MacDougall, Staten Island University Hospital, USA
Similar bleeding rates in patients with VTE and AF treated with DOACs
Presented By
Dr Farès Moustafa, CHU Clermont Ferrand, France
Physical rehabilitation improves health outcomes after pulmonary embolism
Presented By
Dr Stephan Nopp, Medical University Vienna, Austria
Guidelines adherence reduces bleeding risk after surgery and childbirth for VWD patients
Presented By
Dr Brian Craven, Royal Free London NHS Foundation Trust, United Kingdom
Factor V Leiden mutation linked to atrial fibrillation
Presented By
Erin Mathiesen Hald, UiT The Arctic University of Norway, Tromsø, Norway
Increased rates of arterial thromboembolism in cancer patients
Presented By
Dr Frits Mulder, Amsterdam UMC, University of Amsterdam, the Netherlands